For injection- each mL contains 0.25 mg bumetanide, sodium chloride, ammonium acetate as buffer benzyl alcohol as preservative. For tablet- each tablet contain bumetanide USP 1 mg with other excipients accordingly.


It is indicated in patients to treat fluid retention caused due to congestive heart failure, liver disease, or kidney disorder.

Side effects

Mild to moderate side effect has been observed such as hypotension, encephalopathy, joint pain, seizures, encephalopathy


This drug is to be cautiously used in patients with prostatic hypertrophy, liver and kidney disease pregnancy, and lactation.


This drug is contraindicated in patients with anuria, and hepatic coma.

Dosage and administration

Oral- In adult usual dose consists of a tablet 1 mg to be given orally with or without food. Parenteral- 0.5 – 1 mg administrated via IM


We have also established roots and begun this new venture in other countries as well such as Egypt, Argentina, and Hong Kong.

Available Forms